Women’s health: guides on Depo-Provera and care in custody
Guides on the Depo-Provera shot and on health care for women in custody, explained from the label, the studies and the court records.
Updated

Guides in this section
Guide
Depo Provera Side Effects: Bone Loss, Meningioma Risk and Lawsuits
Depo-Provera is a progestin shot given every three months to prevent pregnancy. Its label lists irregular bleeding and weight gain as the most common side effects, carries a boxed warning on Depo Provera bone loss and, since December 2025, also warns about meningioma. Most federal meningioma lawsuits are being resolved through a settlement program whose registration deadline is November 30, 2026.
Guide
Depo-Provera Settlement in MDL 3140: Who Qualifies and the Deadline
The Depo-Provera settlement resolves most of the federal meningioma lawsuits against Pfizer in MDL No. 3140, and as of November 2026 the court’s orders give November 30, 2026 as the deadline for eligible claimants to register. Its terms are confidential, and the parties expected about 80 percent of plaintiffs to qualify.
Guide
Meningioma Symptoms in Women: Signs, Diagnosis, Treatment and Hormones
Meningioma symptoms depend on where the tumor presses: the National Cancer Institute lists vision changes, loss of hearing or smell, confusion, seizures and headaches that are worse in the morning. Many meningiomas cause no symptoms at all and turn up on a scan done for another reason.
Guide
Shackling Pregnant Inmates: What Federal and State Laws Allow in Labor
What 18 U.S.C. § 4322 allows in federal custody, and how far state laws in Illinois, New York, California, Texas and New Jersey go.
Guide
Mothers in Prison: Their Children and Family-Based Treatment Alternatives
Prison nurseries in ten states, family-based treatment, and four state sentencing laws that let a judge weigh a mother’s children.
Medicine, custody and the record
The guides here cover two areas. The first is Depo-Provera, the contraceptive injection given every three months: its label, the research on bone density and meningioma, and the lawsuits over that link. The second is health care in custody, where pregnancy raises its own medical questions; the guides to restraints in pregnancy and mothers in prison belong to this section as much as to the justice section.
None of it replaces a doctor who knows your history.
Depo-Provera: the shot, the label and the lawsuits
Depo-Provera CI is a 150 mg dose of medroxyprogesterone acetate, injected into a muscle every 13 weeks.1 Its label gained a boxed warning on loss of bone mineral density in November 20042 and a warning on meningioma in December 2025,3 after a 2024 French case-control study linked use of a year or more to a higher risk of surgery for the tumor.4
The federal lawsuits over that risk were gathered in February 2025 as MDL No. 3140 in Pensacola, Florida,5 and a Master Settlement Agreement was signed on July 21, 2026.6 The guide to Depo-Provera side effects and meningioma risk covers the label, the study and the court orders in detail, and names the date of the latest order it reflects.
Health care for women in custody
The American College of Obstetricians and Gynecologists holds in Committee Opinion No. 830 that people in custody should get reproductive care by the same clinical guidelines as anyone else,7 and the National Commission on Correctional Health Care opposes restraints on pregnant and postpartum patients.8 Practice lags behind that guidance: a 2021 Government Accountability Office review found that the Bureau of Prisons fully matched national standards on 8 of 16 pregnancy care topics and the U.S. Marshals Service on 3.9
The guide to restraints in pregnancy sets out the federal statute and the state laws. The story of mothers in prison and their children covers prison nursery units, which ten states ran by 2025,10 and family-based treatment, where a mother goes through addiction treatment with her children close by.
How to read a study cited here
The health guides cite two kinds of research. An observational study looks back at people who used a treatment and people who did not; the French meningioma study was one, and because its raw counts were small, the range around its estimate is wide.4 A randomized trial assigns the treatment by chance, so the groups differ only in the thing being tested.
An odds ratio or a hazard ratio describes a comparison between groups. Your own risk depends on your age, your history and how long you have used a drug, and a clinician who knows all three can put the figure in proportion.
Keeping your own record
Ask for the prescribing information of any long-acting drug, and note the date of every injection. If you are in custody, or supporting someone who is, write down each request for care and each reply with its date. The custody guides explain which rules those notes can be measured against.
Questions about the health guides
Are these health guides medical advice?
No. They summarize labels, studies and court records in general terms. Any decision to start, stop or switch a medicine belongs with a clinician who knows your history.
Is Depo-Provera still available after the meningioma warning?
Yes. The December 2025 change added a warning to the prescribing information and left the drug on the market. The label tells clinicians to watch for signs of meningioma and to stop the shot if one is diagnosed.1,3
How long can you stay on Depo-Provera?
The boxed warning says the shot should not be used for more than two years unless other birth control methods are inadequate, because bone density loss grows with longer use.1 Talk to your clinician about how that applies to you.
Do pregnant women in prison get prenatal care?
Usually some, though not always to national standards. The 2021 GAO review found that the Bureau of Prisons fully matched national guidance on only 8 of 16 pregnancy care topics, and the Marshals Service on 3.9
Where do the figures in these guides come from?
From the primary source wherever one exists: the FDA label, the published study, the statute or the court docket. Each figure carries a numbered note that links to it.
References
Sources 10
- ↩Depo-Provera CI (medroxyprogesterone acetate) injectable suspension, prescribing informationPfizer (Pharmacia & Upjohn) · DailyMed, U.S. National Library of Medicine
- ↩FDA “black box” warning on Depo-Provera bone density lossAmerican Medical News
- ↩FDA approves label change for Depo-Provera, adding brain tumor warningNBC News
- ↩Use of progestogens and the risk of intracranial meningioma: national case-control studyRoland N, Neumann A, Hoisnard L, et al. · BMJ 2024;384:e078078
- ↩Transfer Order, In re: Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability LitigationJudicial Panel on Multidistrict Litigation · MDL No. 3140
- ↩In re: Depo-Provera Products Liability Litigation, Case Management Order No. 12U.S. District Court, N.D. Florida · No. 3:25-md-3140, ECF No. 701
- ↩Committee Opinion No. 830: Reproductive Health Care for Incarcerated Pregnant, Postpartum, and Nonpregnant IndividualsAmerican College of Obstetricians and Gynecologists · reaffirmed 2024
- ↩Nonuse of Restraints for Pregnant and Postpartum Incarcerated IndividualsNational Commission on Correctional Health Care · position statement
- ↩Pregnant Women in DOJ Custody: U.S. Marshals Service and Bureau of Prisons Should Better Align Policies with National GuidelinesU.S. Government Accountability Office · GAO-21-147
- ↩A Nebraska prison nursery keeps moms and babies together. But is there a better way?KCUR